Abstract
Three classes of adjuvants - mineral oil emulsions, aluminium salts, and saponin - have long been used to augment immune responses in vaccination. Each has its own advantages and limitations, and during the last decade new adjuvants have been developed. These complement a new group of antigens, including proteins produced by recombinant technology and synthetic peptides, which require adjuvants to elicit protective immune responses. Some of the recently developed adjuvant formulations are already approved for use in human and veterinary vaccines. This paper describes immunomodulating bacterial products and synthetic derivatives, as well as two-phase (lipid in water) vehicles for antigens. It also reviews briefly what adjuvants are required to do and what is known of their mode of action, with special reference to the role of cytokines.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allison, A.C. and Davies, A.J.S. 1971. Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature. 233: 330.
Allison, A.C. and Gregoriadis, G. 1974. Liposomes as immunological adjuvants. Nature. 252: 252.
Allison, A.C. and Byars, N.E. 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and cell-mediated immunity. J. Immun. Methods. 2: 369.
Allison, A.C. and Byars, N.E. 1992. Adjuvants for a new generation of vaccines. Can. J. Infect. Dis., 3: 84B.
Audibert, F.M. and Lise, L.D. 1993. Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today. 14: 281.
Byars, N.E., Fraser-Smith, E.B., Pecyk, R.A. et al. 1994. Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine. 12: 200.
Cumberpatch, M. and Kimber, I. 1995. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84: 31.
Dempsey, P.W., Allison, M.E.D., Akkaraju, S., Goodnow, C.C. and Fearon, D.T. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271: 348.
Doherty, P.C., Allen, W., Eichelberger, M. and Carding, S.R. 1992. Roles of ab and gd T-cell subsets in viral immunity. Annu. Rev. Immunol. 10: 123.
Ellouz, F., Adam, A., Ciorbaru, R. and Lederer, E. 1974. Minimal structural requirements for adjuvant activity of bacterial peptidoglycans. Biochem. Biophys. Res. Comm., 59: 1317.
Finkelman, F.D., Holmes, J., Katona, I.M. et al. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol., 8: 303.
Glück, R. 1995. Liposomal presentation of antigens for human vaccines, in: Powell, M.F., Newman, M.F. (eds.). Vaccine Design: The Subunit and Adjuvant Approach. Plenum Press, New York 1995; pp 325.
Gregoriadis, G. 1990. Immunological adjuvants: A role for liposomes. Immunol. Today. 11: 89.
Gregoriadis, G., Wang, Z., Barenholz, Y. and Francis, M.J. 1993. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Immunology. 80: 535.
Hamaoka, T., Katz, D.H., Benacerraf, B. 1973. Hapten-specific antibody responses in mice. II. Cooperative interactions between adoptively transferred T-and B-lymphocytes in the development of an IgE response. J. Exp. Med., 138: 538.
Heufler, C., Koch, F. and Schüler, G. 1988. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med., 167: 700.
Kaminski, M.S., Kitamura, K. and Maloney, D.G. 1986. Importance of antibody isotype in monoclonal anti-idiotype therapy of murine B-cell lymphoma. A study of hybridoma class switch variants. J. Immunol., 136: 1123.
Kenney, J.S., Hughes B.M. and Allison, A.C. 1989. Determination of antibody affinity and concentration by solution-phase microradioimmunoassay, in: Zola, H. (ed.) Laboratory Methods in Immunology. CRC Press, Boca Raton; pp 209.
Kenney, J.S., Hughes, B.W., Masada, M.P. and Allison, A.C. 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods. 21: 157.
Macatonia, S.E., Hosken, N.A., Litton, M., Vieira, P., Hsieh, C.-S., culpepper, J.A., Wysocka, M., Trinchieri, G., Murphy, K.M. and O’Garra, A. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T-cells. J. Immunol. 154: 5071.
MacLennan, I.C.M. 1994. Germinal centers. Annu. Rev. Immunol., 12: 117.
Meeusen, E.N.T., Premier, R.R. and Brandon, M.R. 1996. Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol. Today. 17: 421.
Persson, G.R., Engel, D., Whitney, C., Darueau, R., Weinberg, A., Brunsvold, M. and Page, R.C. 1994. Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect. Immun., 62: 1026.
Reichmann, L., Clark, M., Waldmann, H. and Winter, G. 1988. Reshaping human antibodies for therapy. Nature. 332: 323.
Ribi, E., Ulrich, J.T. and Masihi, K.N. 1993. Immunopotentiating activities of monophosphoryl lipid A, in: Majde, J.A. (ed.) Immunopharmacology of Infectious Diseases: Vaccine Adjuvants and Modulation of Non-specific Resistance. Alan R. Liss, New York; pp 101.
Ron, Y. and Sprent, J. 1987. T-cell priming in vitro: A major role for B-cells in presenting antigen to T-cells in lymph nodes. J. Immunol., 138: 2848.
Rothel, J.S., Corner, L.A., Seaw, H.-F., Wood, P.R. and Lightowlers, M.W. 1996. Antigen-specific IgA secreting cells induced by peripheral vaccination. Immunol. Cell. Biol., 74: 278.
Schijns, V.E.C.J., Haagmans, B., Rijke, E.O., Huang, S., Aguet, M. and Horzunek, M.C. 1994. IFN-y receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153: 2029.
Schulz, M., Zinkernagel, R.M. and Hengartner, H. 1991. Peptide-induced protection by cytotoxic T-cells. Proc. Natl. Acad. Sci. USA. 88: 991.
Spitznagel, J.K. and Allison, A.C. 1970. Mode of action of adjuvants: effects on antibody responses to macrophages-associated bovine serum albumin. J. Immunol. 104: 128.
Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271.
Strobl, H., Riedl, E., Scheinecker, G, Bello-Fernandez, G, Pickl, W.F., Rappersberger, K., Majdic, O. and Knapp., W. 1996. TGF-β1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157: 1499.
Szakal, A.K., Kosco, M.H. and Tew, J.G. 1989. Microanatomy of lymphoid tissue during humoral immune responses: Structure-function relationships. Annu. Rev. Immunol. 7: 91.
Toes, R.E.M., Blom, R.J.J., Offringa, R., Kast, W.M. and Melief, C.J.M. 1996. Enhanced tumor outgrowth after peptide vaccination. J. Immunol. 156: 3911.
Unanue, E.R., Askonas, B.A. and Allison, A.C. 1969. A role of macrophages in the stimulation of immune responses by adjuvants. J. Immunol. 103: 71.
Van Rooijen, N. and Sanders, A. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol Methods. 174: 83.
Vijay, H.M., Lavregne, G., Huang, H. and Bernstein, I.L. 1979. Preferential synthesis of IgE reaginic antibodies in rats immunized with alum adsorbed antigens. Int. Arch. Allergy Appl. Immunol. 59: 227.
Walker, B.D., Flexner, C. and Paradis, T.J. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T-lymphocytes in infected individuals. Science. 240: 64.
Waters, R.V., Terrell, T.G. and Jones, G.H. 1986. Uveitis induction in the rabbit by muramyl dipeptides. Infect. Immun., 51: 816.
White, R.G. 1976. The adjuvant effect of microbial products on the immune response. Rev. Microbiol., 30: 579.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Allison, A.C. (1997). The Role of Cytokines in the Action of Immunological Adjuvants. In: Gregoriadis, G., McCormack, B., Allison, A.C. (eds) Vaccine Design. NATO ASI Series, vol 293. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0062-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0062-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0064-7
Online ISBN: 978-1-4899-0062-3
eBook Packages: Springer Book Archive